INVO Bioscience SG&A Expense (TTM) Trends

INVO Bioscience Inc (INVO)

0.79 +0.03 (+3.93%) USD | NASDAQ | Jul 05, 16:00

0.79 0.00 (0.00%) After-Hours: 17:43

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2007. Upgrade now.

Date	Value
March 31, 2024	6.596M
December 31, 2023	7.486M
September 30, 2023	8.299M
June 30, 2023	9.358M
March 31, 2023	9.760M
December 31, 2022	10.12M
September 30, 2022	9.889M
June 30, 2022	9.989M
March 31, 2022	9.594M
December 31, 2021	9.015M
September 30, 2021	8.335M
June 30, 2021	7.382M
March 31, 2021	6.585M
December 31, 2020	6.065M
September 30, 2020	5.353M
June 30, 2020	4.780M
March 31, 2020	4.196M
December 31, 2019	3.129M
September 30, 2019	2.712M
June 30, 2019	2.121M
March 31, 2019	3.336M
December 31, 2018	3.038M
September 30, 2018	2.681M
June 30, 2018	2.581M
March 31, 2018	0.8955M

Date	Value
December 31, 2017	0.8706M
September 30, 2017	0.8801M
June 30, 2017	0.8991M
March 31, 2017	2.156M
December 31, 2016	2.146M
September 30, 2016	2.105M
June 30, 2016	2.003M
March 31, 2016	0.6613M
December 31, 2015	0.599M
September 30, 2015	0.5177M
June 30, 2015	0.5829M
March 31, 2015	0.6895M
December 31, 2011	0.7572M
September 30, 2011	1.037M
June 30, 2011	1.218M
March 31, 2011	1.316M
December 31, 2010	1.561M
September 30, 2010	1.590M
June 30, 2010	1.520M
March 31, 2010	1.647M
December 31, 2009	1.857M
September 30, 2009	3.192M
June 30, 2009	2.911M
March 31, 2009	2.724M
December 31, 2008	2.085M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

2.712M

Minimum

Sep 2019

10.12M

Maximum

Dec 2022

7.297M

Average

7.486M

Median

Dec 2023

SG&A Expense (TTM) Benchmarks